Deep learning based variant calling using machine learning
AssigneeMyriad Women's Health, Inc.
InventorsSun HONG, Kyle BEAUCHAMP, Kevin HAAS
Life of this patent
Estimating the term…
Loading patent…
AssigneeMyriad Women's Health, Inc.
InventorsSun HONG, Kyle BEAUCHAMP, Kevin HAAS
Estimating the term…
A system and method for determining a respective carrier status of an individual is provided. In one implementation, a method includes training a neural network model based on predetermined information related to at least one genetic variant and determining the respective carrier status based on a normalized read depth for the gene in a genome of the individual and allele dosage data for the gene using a machine learning algorithm. The method is configured to receive, as inputs, the normalized read depth and allele dosage data, and output the respective carrier status of the individual for the at least one genetic variant. In another implementation a system includes a recurrent neural network. The recurrent neural network includes a plurality of long short-term memory (LSTM) network cells linked sequentially in the recurrent neural network, a plurality of layers of long short-term memory (LSTM) network cells; and a fully connected sigmoid module.
A method for determining a respective carrier status of an individual, the method comprising:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for determining a number of functional copies of a gene within a genome of an individual, the method comprising:
A system adapted to determine a respective carrier status of an individual comprising:
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.